These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 10096550)

  • 1. Differential behaviors toward ultraviolet A and B radiation of fibroblasts and keratinocytes from normal and DNA-repair-deficient patients.
    Otto AI; Riou L; Marionnet C; Mori T; Sarasin A; Magnaldo T
    Cancer Res; 1999 Mar; 59(6):1212-8. PubMed ID: 10096550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cancer-free phenotype in trichothiodystrophy is unrelated to its repair defect.
    Berneburg M; Clingen PH; Harcourt SA; Lowe JE; Taylor EM; Green MH; Krutmann J; Arlett CF; Lehmann AR
    Cancer Res; 2000 Jan; 60(2):431-8. PubMed ID: 10667598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of UV-induced mutation spectra in human XP-D/ERCC2 gene-mutated xeroderma pigmentosum and trichothiodystrophy cells.
    Marionnet C; Benoit A; Benhamou S; Sarasin A; Stary A
    J Mol Biol; 1995 Oct; 252(5):550-62. PubMed ID: 7563073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged p53 protein accumulation in trichothiodystrophy fibroblasts dependent on unrepaired pyrimidine dimers on the transcribed strands of cellular genes.
    Dumaz N; Duthu A; Ehrhart JC; Drougard C; Appella E; Anderson CW; May P; Sarasin A; Daya-Grosjean L
    Mol Carcinog; 1997 Dec; 20(4):340-7. PubMed ID: 9433478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse model for the DNA repair/basal transcription disorder trichothiodystrophy reveals cancer predisposition.
    de Boer J; van Steeg H; Berg RJ; Garssen J; de Wit J; van Oostrum CT; Beems RB; van der Horst GT; van Kreijl CF; de Gruijl FR; Bootsma D; Hoeijmakers JH; Weeda G
    Cancer Res; 1999 Jul; 59(14):3489-94. PubMed ID: 10416615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of nucleotide excision repair defects between XPD-mutated fibroblasts derived from trichothiodystrophy and xeroderma pigmentosum patients.
    Nishiwaki T; Kobayashi N; Iwamoto T; Yamamoto A; Sugiura S; Liu YC; Sarasin A; Okahashi Y; Hirano M; Ueno S; Mori T
    DNA Repair (Amst); 2008 Dec; 7(12):1990-8. PubMed ID: 18817897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconstruction of DNA repair-deficient xeroderma pigmentosum skin in vitro: a model to study hypersensitivity to UV light.
    Bernerd F; Asselineau D; Frechet M; Sarasin A; Magnaldo T
    Photochem Photobiol; 2005; 81(1):19-24. PubMed ID: 15369409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A lack of radiation-induced ornithine decarboxylase activity prevents enhanced reactivation of herpes simplex virus and is linked to non-cancer proneness in xeroderma pigmentosum patients.
    Terleth C; van Laar T; Schouten R; van Steeg H; Hodemaekers H; Wormhoudt T; Cornelissen-Steijger PD; Abrahams PJ; van der Eb AJ
    Cancer Res; 1997 Oct; 57(19):4384-92. PubMed ID: 9331102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of normal DNA repair and mutagenesis in trichothiodystrophy cells after transduction of the XPD human gene.
    Marionnet C; Quilliet X; Benoit A; Armier J; Sarasin A; Stary A
    Cancer Res; 1996 Dec; 56(23):5450-6. PubMed ID: 8968100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced levels of UV-induced unscheduled DNA synthesis in epidermal keratinocytes of patients with xeroderma pigmentosum and correlation with development of skin neoplasms.
    Kondo S; Satoh Y; Kuroki T
    Cancer Res; 1989 Apr; 49(8):1927-30. PubMed ID: 2467739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementation assays adapted for DNA repair-deficient keratinocytes.
    Fréchet M; Bergoglio V; Chevallier-Lagente O; Sarasin A; Magnaldo T
    Methods Mol Biol; 2006; 314():9-23. PubMed ID: 16673870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cancer and DNA repair-deficient diseases.
    Sarasin A; Stary A
    Cancer Detect Prev; 1997; 21(5):406-11. PubMed ID: 9307843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional lentiviral vectors for xeroderma pigmentosum gene therapy.
    Marchetto MC; Correa RG; Menck CF; Muotri AR
    J Biotechnol; 2006 Dec; 126(4):424-30. PubMed ID: 16857285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic correction of DNA repair-deficient/cancer-prone xeroderma pigmentosum group C keratinocytes.
    Arnaudeau-Bégard C; Brellier F; Chevallier-Lagente O; Hoeijmakers J; Bernerd F; Sarasin A; Magnaldo T
    Hum Gene Ther; 2003 Jul; 14(10):983-96. PubMed ID: 12869216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical symptoms and DNA repair characteristics of xeroderma pigmentosum patients from Germany.
    Thielmann HW; Popanda O; Edler L; Jung EG
    Cancer Res; 1991 Jul; 51(13):3456-70. PubMed ID: 2054785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trichothiodystrophy, a human DNA repair disorder with heterogeneity in the cellular response to ultraviolet light.
    Lehmann AR; Arlett CF; Broughton BC; Harcourt SA; Steingrimsdottir H; Stefanini M; Malcolm A; Taylor R; Natarajan AT; Green S
    Cancer Res; 1988 Nov; 48(21):6090-6. PubMed ID: 2458832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xeroderma pigmentosum patients belonging to complementation group F and efficient liquid-holding recovery of ultraviolet damage.
    Nishigori C; Fujisawa H; Uyeno K; Kawaguchi T; Takebe H
    Photodermatol Photoimmunol Photomed; 1991 Aug; 8(4):146-50. PubMed ID: 1814424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different sensitivities to ultraviolet light-induced cytotoxicity and sister chromatid exchanges in xeroderma pigmentosum and Bloom's syndrome fibroblasts.
    Mamada A; Kondo S; Satoh Y
    Photodermatol; 1989 Jun; 6(3):124-30. PubMed ID: 2762203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of matrix metalloproteinase 1 in dermal fibroblasts from DNA repair-deficient/cancer-prone xeroderma pigmentosum group C patients.
    Fréchet M; Warrick E; Vioux C; Chevallier O; Spatz A; Benhamou S; Sarasin A; Bernerd F; Magnaldo T
    Oncogene; 2008 Sep; 27(39):5223-32. PubMed ID: 18469853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xeroderma pigmentosum complementation group E: a case report.
    Kawada A; Satoh Y; Fujiwara Y
    Photodermatol; 1986 Aug; 3(4):233-8. PubMed ID: 3774595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.